Shree Benzophen Industries
In the Mar 2017 quarter, revenue was ₹0.24 Cr, against ₹0.34 Cr a year earlier and net profit was ₹0.15 Cr, against ₹0.07 Cr a year earlier (compared with Mar 2016). Promoters held 45.49% of Shree Benzophen Industries in Mar 2018, unchanged from Dec 2017.
Peer Comparison
Commodities › Chemicals & Petrochemicals › Commodity Chemicals
| ₹2,364.20 | 32.42 | 70,081 Cr | 4.58 | 0.21% | 13.07% | 14.64% | 17,997 Cr | 2,162 Cr | |
| ₹600.50 | — | 15,298 Cr | 0.72 | 1.84% | -7.73% | -2.69% | 15,521 Cr | -1,971 Cr | |
| ₹1,167.10 | 14.97 | 14,733 Cr | 2.15 | 0.84% | 9.90% | 11.30% | 12,189 Cr | 984 Cr | |
| ₹3,496.35 | 104.84 | 7,564 Cr | 10.47 | 0.13% | 18.80% | 25.38% | 725 Cr | 68 Cr | |
| ₹514.20 | 7.29 | 7,556 Cr | 0.83 | 4.12% | 8.75% | 10.38% | 8,860 Cr | 1,037 Cr | |
| ₹551.20 | 60.97 | 4,048 Cr | 0.78 | 3.20% | -0.05% | 1.29% | 4,622 Cr | 66 Cr | |
| ₹383.60 | 7.64 | 3,534 Cr | 0.99 | 3.04% | 13.30% | 16.87% | 3,138 Cr | 473 Cr | |
Shree Benzophen Industries (this company) | — | — | — | — | — | — | — | 1 Cr | — |
| Median 8 companies | ₹600.50 | 23.70 | 7,564 Cr | 0.99 | 1.84% | 9.90% | 11.30% | 6,741 Cr | 473 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Growth Rate
change over 1 year
change over 1 year
Quarterly Results
| Particulars | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.35 | 0.4 | 0.4 | 0.4 | 0.33 | 0.37 | 0.26 | 0.29 | 0.34 | 0.3 | 0.23 | 0.26 | 0.24 |
| Expenses | 0.44 | 0.47 | 0.47 | 0.44 | 0.41 | 0.37 | 0.39 | 0.32 | 0.46 | 0.33 | 0.33 | 0.49 | 0.22 |
| Operating Profit | -0.09 | -0.07 | -0.07 | -0.04 | -0.08 | 0 | -0.13 | -0.03 | -0.12 | -0.03 | -0.1 | -0.23 | 0.02 |
| OPM % | -25.71% | -17.5% | -17.5% | -10% | -24.24% | 0% | -50% | -10.34% | -35.29% | -10% | -43.48% | -88.46% | 8.33% |
| Other Income | 0.12 | 0.12 | 0.12 | 0.12 | 0.15 | 0.12 | 0.13 | 0.13 | 0.27 | 0.13 | 0.13 | 0.13 | 0.14 |
| Interest | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Depreciation | 0.08 | 0 | 0 | 0 | 0.08 | 0 | 0 | 0 | 0.07 | 0.07 | 0 | 0 | 0 |
| PBT | -0.08 | 0.03 | 0.03 | 0.06 | -0.03 | 0.1 | -0.02 | 0.08 | 0.07 | 0.02 | 0.02 | -0.11 | 0.15 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 50% | 0% | 0% | 0% |
| Net Profit | -0.08 | 0.03 | 0.03 | 0.06 | -0.02 | 0.1 | -0.02 | 0.08 | 0.07 | 0.01 | 0.02 | -0.11 | 0.15 |
| EPS (₹) | -0.12 | 0.04 | 0.04 | 0.09 | -0.03 | 0.14 | -0.03 | 0.12 | 0.1 | 0.01 | 0.03 | -0.16 | 0.22 |
Profit & Loss
| Particulars | Mar 2006 | Mar 2007 | Mar 2009 | Mar 2010 | TTM |
|---|---|---|---|---|---|
| Sales | 0.49 | 0.7 | 1.13 | 1.16 | 1.03 |
| Expenses | 0.53 | 0.72 | 1.21 | 1.15 | 1.37 |
| Operating Profit | -0.04 | -0.02 | -0.08 | 0.01 | -0.34 |
| OPM % | -8.16% | -2.86% | -7.08% | 0.86% | -33.01% |
| Other Income | -0.02 | 0.23 | 0.38 | 0.45 | 0.53 |
| Interest | 0.04 | 0.17 | 0.18 | 0.18 | 0.04 |
| Depreciation | 0.56 | 0.34 | 0.05 | 0.06 | 0.07 |
| PBT | -0.66 | -0.3 | 0.07 | 0.22 | 0.08 |
| Tax % | 0% | 0% | 0% | 0% | — |
| Net Profit | -0.66 | -0.3 | 0.07 | 0.22 | 0.07 |
| EPS (₹) | -0.96 | -0.43 | 0.1 | 0.32 | 0.1 |
| Div. Payout % | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2006 | Mar 2007 | Mar 2009 | Mar 2010 |
|---|---|---|---|---|
| Equity Capital | 6.9 | 6.9 | 6.9 | 6.9 |
| Reserves | -6.18 | -6.48 | -6.36 | -6.14 |
| Borrowings | 1.34 | 1.28 | 1.14 | 1.06 |
| Other Liabilities | 0.06 | 0.16 | 0.17 | 0.16 |
| Total Liabilities | 2.12 | 1.86 | 1.85 | 1.98 |
| Fixed Assets | 1.61 | 1.27 | 1.17 | 1.22 |
| CWIP | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 |
| Other Assets | 0.51 | 0.59 | 0.68 | 0.76 |
| Total Assets | 2.12 | 1.86 | 1.85 | 1.98 |
Cash Flow
| Particulars | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 6 | 5 | 8 | 9 | 9 | 20 | 60 | 36 | 81 | 77 | 44 | 50 |
| Investing | -8 | -2 | -2 | -7 | -29 | -12 | -47 | -20 | -47 | -71 | -24 | -27 |
| Financing | 1 | -1 | 0 | 4 | 33 | -1 | -12 | -4 | -15 | -14 | -15 | -13 |
| Net Cash Flow | -1 | 2 | 5 | 7 | 12 | 6 | 1 | 12 | 18 | -8 | 4 | 10 |
Ratios
| Particulars | Mar 2006 | Mar 2007 | Mar 2009 | Mar 2010 |
|---|---|---|---|---|
| Debtor Days | 29.8 | 57.36 | 48.45 | 59.78 |
| Inventory Days | 140 | 60.83 | 31.74 | 56.15 |
| Days Payable | 28.08 | 52.14 | 26.45 | 28.08 |
| Cash Conversion Cycle | 142 | 66.05 | 53.74 | 87.86 |
| Working Capital Days | 67.04 | 73 | 77.52 | 157 |
| ROCE % | — | -6.91% | — | 22.86% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Shree Benzophen Industries insights
37 extracted metrics + investor summaries across FY06–FY26.
Documents
Frequently Asked Questions about Shree Benzophen Industries
Where is Shree Benzophen Industries Ltd (531389) listed?
Which sector does Shree Benzophen Industries Ltd belong to?
Company Information
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/531389.md for Shree Benzophen Industries Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.